Updated on 29 August 2012
Currently, new minimally invasive surgery are three-to-five times more expensive than conventional surgery opening room to next generation of open repair technologies that are low cost.
One such company which is focusing on next generation open repair technologies is Spinofix and Spinofix International. Spinofix, with its head office in Irivne, California, and an international office in Taiwan and a proposed office in Singapore, has developed low cost treatment options that provide potentially better results that conventional treatments and cost as much or less than conventional treatment, which is a win-win situation.
Minimally invasive spine surgery vs open surgery
One of the biggest reasons to get spine surgery is intractable back pain. Patients resort to spine surgery because they can't take it anymore. Their goal is to get rid of the pain once for all.
Surgeons practicing less invasive or minimally invasive spine surgery are still learning the techniques, patients would rather prefer to do a conventional treatment because they are aware of the outcomes, which is similar to less invasive surgery. The only difference is quicker healing time (couple of weeks). Patient's and payers (insurance companies) prefer less costly and more predictable outcome that are less invasive with a chance to undergo a second revision surgery, if things did not go right the first time.
Investment in Spine Technology
Many investors looking to invest in spine technology may think minimally invasive technology is the way to go. Actually, it's the paradox. Next generation technologies, which are less costly and improvements in the open repair, are more popular and will stay for the next two decades. New technologies in spine fusion will replace the conventional treatments slowly, thus bridging the gap between the conventional treatment and minimally invasive surgery. Spinofix's cross connector system is one of the technology that the companies are using to bridge the gap.